EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of advanced head and neck squamous cell carcinoma with intratumoral cisplatin/epinephrine injectable gel Phase III multicenter studies



Treatment of advanced head and neck squamous cell carcinoma with intratumoral cisplatin/epinephrine injectable gel Phase III multicenter studies



European Journal of Cancer 37(Supplement 6): S102, October




(PDF 0-2 workdays service: $29.90)

Accession: 035980862

Download citation: RISBibTeXText



Related references

The role of intratumoral therapy with cisplatin/epinephrine injectable gel in the management of advanced squamous cell carcinoma of the head and neck. Archives of Otolaryngology--Head & Neck Surgery 128(8): 880-885, 2002

Intratumoral cisplatin/epinephrine gel in advanced head and neck cancer: a multicenter, randomized, double-blind, phase III study in North America. Head & Neck 25(9): 717-731, 2003

Neo-adjuvant chemo- -therapy of advanced squamous-cell head and neck carcinoma A multicenter, phase III, randomized study comparing cisplatin plus 5-fluorouracil with cisplatin plus 5-FU plus recombinant interleukin 2. Cancer Immunology Immunotherapy 47(3): 149-156, 1998

Neo-adjuvant chemo-(immuno)-therapy of advanced squamous-cell head and neck carcinoma: A multicenter, phase III, randomized study comparing cisplatin plus 5-fluorouracil (5-FU) with cisplatin plus 5-FU plus recombinant interleukin 2. Cancer Immunology Immunotherapy 47(3): 149-156, 1998

Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin+5-fluorouracil (5-FU) with cisplatin +5-FU+recombinant interleukin 2. Cancer Immunology, ImmunoTherapy 47(3): 149-156, 1998

Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2. Cancer Immunology, ImmunoTherapy 47(3): 149-156, 1998

A multicenter phase II study of tgDCC-E1A for the intratumoral treatment of patients with recurrent head and neck squamous cell carcinoma. Head & Neck 24(7): 661-669, 2002

Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: a multicenter phase II trial. Annals of Oncology 6(10): 987-991, 1995

Ifosfamide cisplatin and 13-cis retinoic acid in the treatment of advanced squamous cell carcinoma of the head and neck A phase II study. Proceedings of the American Association for Cancer Research Annual Meeting 40: 190, March, 1999

Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study. Annals of Oncology 26(9): 1941-1947, 2016

Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck. Results of a phase II Multicenter Study. Cancer 79(7): 1394-1400, 1997

Cisplatin and bleomycin in the treatment of advanced or recurrent squamous cell carcinoma of the head and neck. A randomized facultative Phase III controlled study. Sonderbande Zur Strahlentherapie und Onkologie 81: 141-150, 1987

A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck. Cancer 85(4): 952-959, Feb 15, 1999

Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck: a randomised phase II study. European Journal of Cancer 41(9): 1254-1260, 2005

A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck. Cancer 119(4): 766-773, 2013